[1] 国家卫生健康委, 国家中医药管理局. 新型冠状病毒感染的肺炎诊疗方案(试行第六版)发布[EB/OL].医政管理局,2020-02-19. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml.
[2] Rubin EJ, Baden LR, Morrissey S, et al.Medical Journals and the 2019-nCoV Outbreak[J]. N Engl J Med, 2020,382(9): 866.
[3] Chan JF, Yuan S, Kok KH, et al.A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster[J]. Lancet,2020,395(10223): 514-523.
[4] Chen Y, Liu Q, Guo D.Emerging coronaviruses: Genome structure, replication, and pathogenesis[J]. J Med Virol,2020, 92(4): 418-423.
[5] Su S, Wong G, Shi W, et al.Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses[J]. Trends Microbiol,2016, 24(6): 490-502.
[6] Zhu N, Zhang D, Wang W, et al.A Novel Coronavirus from Patients with Pneumonia in China, 2019[J]. N Engl J Med,2020, 382(8): 727-733.
[7] Weiss SR, Leibowitz JL.Coronavirus pathogenesis[J]. Adv Virus Res,2011,81: 85-164.
[8] Huang C, Wang Y, Li X, et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet,2020,395(10223): 497-506.
[9] Phan T.Novel coronavirus: From discovery to clinical diagnostics[J]. Infect Genet Evol,2020,79: 104211.
[10] Oudit GY1, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS[J]. Eur J Clin Invest,2009, 39(7): 618-25.
[11] 苏亦瑜. 国家卫健委公布17例新型肺炎死亡病例:最小48最大89岁多有既往慢病史[EB/OL]. 中国新闻网,2020-01-23. http://www.chinanews.com/sh/2020/01-23/9067874.shtml.
[12] 姜雨薇. 国家卫健委公布17例新型肺炎死亡病例病情:多为60岁以上[EB/OL]. 中国新闻网,2020-01-23. http://www.chinanews.com/gn/2020/01-23/9068034.shtml.
[13] 侯涛. 武汉金银潭医生前线手记:新型冠状病毒肺炎临床特征初探[EB/OL]. 医脉通,2020-01-29. https://news.medlive.cn/all/info-news/show-165664_97.html
[14] Xu X, Chen P, Wang J, et al.Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission[J]. Sci China Life Sci,2020,63(3): 457-460.
[15] 张梅,李闯. 新型冠状病毒肺炎与心血管疾病[J/OL]. 武警医学,31(2).https://doi.org/10.14010/j.cnki.wjyx.20200215.001.
[16] 林果为,王吉耀,葛均波. 实用内科学[M]. 第15版. 北京:人民卫生出版社,2017:818-828,1394-1421.
[17] 郭栋,郭万刚,刘鹏云,等. 新型冠状病毒感染的心脏表现[J/OL]. 心脏杂志,2020-02-24. http://kns.cnki.net/kcms/detail/61.1268.R.20200214.0853.001.html.
[18] 朱运贵,邓紫薇,刘丽华,等. 新冠肺炎诊疗方案治疗药物信息汇编(第一版)[J/OL]. 中南药学:1-14[2020-02-26]. http://kns.cnki.net/kcms/detail/43.1408.R.20200221.0859.002.html.
[19] 杨宝峰,苏定冯. 药理学[M]. 9版.北京:人民卫生出版社,2018:327-334,409-411.
[20] Wangpatharawanit P, Sungkanuparph S.Switching Lopinavir/Ritonavir to Atazanavir/Ritonavir vs Adding Atorvastatin in HIV-Infected Patients Receiving Second-Line Antiretroviral Therapy With Hypercholesterolemia: A Randomized Controlled Trial[J].Clin Infect Dis, 2016, 63(6): 818-20.
[21] 李太生,曹玮,翁利,等. 北京协和医院关于“新型冠状病毒感染的肺炎”诊疗建议方案(V2.0)[J/OL]. 协和医学杂志,1-5[2020-02-24].http://kns.cnki.net/kcms/detail/11.5882.r.20200130.1430.002.html.
[22] Khamitov RA, Loginova SIa, Shchukina VN, et al.Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures[J].Vopr Virusol, 2008 , 53(4): 9-13.
[23] 张劲农. 武汉协和医院处置2019新型冠状病毒感染策略及说明[EB/OL]. 丁香园论坛,2020-01-22. https://www.dxy.cn/bbs/newweb/pc/post/42662254.
[24] Holshue ML, DeBolt C, Lindquist S, et al. First Case of 2019 Novel Coronavirus in the United States[J]. N Engl J Med,2020,382(10): 929-936.
[25] Sheahan TP, Sims AC, Graham RL, et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses[J]. Sci Transl Med,2017,9(396): eaal3653.
[26] Yu Zhao, Zixian Zhao, Yujia Wang, et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan2019-nCov[EB/OL]. Bio Rxiv, 2020-02-13. https://www.biorxiv.org/content/10.1101/2020.01.26.919985v2.
[27] Imai Y, Kuba K, Rao S, et al.Angiotensin-converting enzyme 2 protects from severe acute lung[J]. Nature, 2005, 436(7047): 112-116.
[28] Mortensen EM, Restrepo MI, Copeland LA, et al.Association of hydrophilic versus lipophilic angiotensin-converting enzyme inhibitor use on pneumonia-related mortality[J]. Am J Med Sci, 2008, 336(6): 462-426.
[29] Ohkubo T, Chapman N, Neal B, et al.Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk[J].Am J Respir Crit Care Med, 2004, 169(9): 1041-1045.
[30] Ohkubo T, Chapman N, Neal B, et al.Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk[J].Am J Respir Crit Care Med, 2004, 169(9): 1041-1045.
[31] 胡盛寿,高润霖,刘力生,等. 《中国心血管病报告2018》概要[J]. 中国循环杂志,2019,34(3):209-220.
[32] 张健,张宇辉. 多中心、前瞻性中国心力衰竭注册登记研究—病因、临床特点和治疗情况初步分析[J]. 中国循环杂志,2015,30(5):413-416.
[33] Chen N, Zhou M, Dong X, et al.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet,2020,395(10223): 507-513.
[34] Tamis-Holland JE, Jneid H, Reynolds HR, et al.Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease.A Scientific Statement From the American Heart Association[J]. Circulation, 2019, 139(18): e891-e908.
[35] 中国医师协会呼吸医师分会危重症医学专业委员会,中华医学会呼吸病学分会危重症医学学组. 体外膜式氧合治疗成人重症呼吸衰竭推荐意见[J]. 中华结核和呼吸杂志,2019,42(9):660-684.
[36] 杨峰,王粮山. 成人体外膜氧合循环辅助专家共识[J]. 中华重症医学电子杂志(网络版),2018,4(2):114-122.
[37] 陈灏珠,钟南山,陆再英,等. 内科学[M]. 第9版. 北京:人民卫生出版社,2018:526-527. |
